[Percutaneous use of vasoactive drugs in the diagnosis and treatment of erectile impotence].
The Authors report their experience of topical and intracavernous treatment with papaverine and phentolamine in patients with erectile dysfunction from May 1988 to March 1992. Topical application of drug cream proves efficacious both alone or combined with intracavernous injection with PGE1. Topical treatment besides may be carried out without systemic or local complications.
Pastorini
S
S
Divisione di Urologia, Ospedale Mauriziano Umberto L, Torino.
Marino
G
G
Cocimano
V
V
Marten Perolino
R
R
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000188:drug therapy*; D005782:Gels; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage* / Q000627:therapeutic use; D010413:Penis; D010646:Phentolamine / Q000008:administration & dosage* / Q000627:therapeutic use
D004338:Drug Combinations; D005782:Gels; D010208:Papaverine; D000527:Alprostadil; D010646:Phentolamine
Impiego percutaneo di farmaci vasoattivi nella diagnosi e nella terapia dell'impotenza erettile.